Agios Pharmaceuticals (AGIO) R&D US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D, bln rub | 410.9 | 367.5 | 257.0 | 279.9 | 288.9 | 291.6 | |||
Changes by years, y/y, % | +20% | -11% | -30% | +9% | +3% | -3.3% |
Agios Pharmaceuticals. R&D, bln rub
Agios Pharmaceuticals. R&D, changes, %
Agios Pharmaceuticals. R&D, sum by quarters, bln rub
Agios Pharmaceuticals (AGIO) R&D US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
R&D, bln rub | 81.8 | 76.1 | 67.3 | 75.8 | 72.5 | 291.6 | ||
Changes by years, y/y, % | +26% | +8% | 0% | +10% | -11% | |||
Changes by quarters, q/q, % | +19% | -7% | -12% | +13% | -4% |